References
- AhmedRMPatersonRWWarrenJDBiomarkers in dementia: clinical utility and new directionsJ Neurol Neurosurg Psychiatry201485121426143425261571
- ShawLMVandersticheleHKnapik-CzajkaMAlzheimer’s Disease Neuroimaging InitiativeCerebrospinal fluid biomarker signature in Alzheimer’s disease neuroimaging initiative subjectsAnn Neurol20096540341319296504
- TosunDSchuffNTruran-SacreyDAlzheimer’s Disease Neuroimaging InitiativeRelations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI studyNeurobiol Aging20103181340135420570401
- BlennowKCSF biomarkers for mild cognitive impairmentJ Intern Med2004256322423415324365
- TondelliMBedinRChiariARole of cerebrospinal fluid biomarkers to predict conversion to dementia in patients with mild cognitive impairment: a clinical cohort studyClin Chem Lab Med201553345346025274948
- CorderEHSaundersAMStrittmatterWJGene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset familiesScience19932619219238346443
- HuangYA beta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer’s diseaseTrends Mol Med201016628729420537952
- LautnerRPalmqvistSMattssonNAlzheimer’s Disease Neuroimaging InitiativeApolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer diseaseJAMA Psychiatry201471101183119125162367
- VemuriPWisteHJWeigandSDEffect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer diseaseAnn Neurol201067330831620373342
- FarrerLACupplesLAHainesJLEffects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. APOE and Alzheimer Disease Meta Analysis ConsortiumJAMA199727816134913569343467
- BaoXQLiNWangTFLZ alleviates the memory deficits in transgenic mouse model of Alzheimer’s disease via decreasing beta-amyloid production and tau hyperphosphorylationPLoS One2013811e7803324223757
- ChooIHLeeDYKimJWRelationship of amyloid-β burden with age-at-onset in Alzheimer diseaseAm J Geriatr Psychiatry201119762763421709608
- McKhannGDrachmanDFolsteinMKatzmanRPriceDStadlanEMClinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s DiseaseNeurology19843479399446610841
- MorrisJCMohsRCRogersHFillenbaumGHeymanAConsortium to establish a registry for Alzheimer’s disease (CERAD) clinical and neuropsychological assessment of Alzheimer’s diseasePsychopharmacol Bull19882446416523249766
- FolsteinMFFolsteinSEMcHughPRMini-mental state: a practical method for grading the cognitive state of patients for the clinicianJ Psychiatr Res19751231891981202204
- MorrisJCThe Clinical Dementia Rating (CDR): current version and scoring rulesNeurology19934311241224148232972
- GeninEHannequinDWallonDAPOE and Alzheimer disease: a major gene with semi-dominant inheritanceMol Psychiatry201116990390721556001
- YuJTTanLHardyJApolipoprotein E in Alzheimer’s disease: an updateAnnu Rev Neurosci2014377910024821312
- DumurgierJLaplancheJLMouton-LigerFThe screening of Alzheimer’s patients with CSF biomarkers, modulates the distribution of APOE genotype: impact on clinical trialsJ Neurol201426161187119524728335
- BatemanRJMunsellLYMorrisJCSwarmRYarasheskiKEHoltzmanDMHuman amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivoNat Med200612785686116799555
- KimJBasakJMHoltzmanDMThe role of apolipoprotein E in Alzheimer’s diseaseNeuron200963328730319679070
- HollandDDesikanRSDaleAMMcEvoyLKHigher rates of decline for women and apolipoprotein E epsilon4 carriers. Alzheimer’s Disease Neuroimaging InitiativeAJNR Am J Neuroradiol201334122287229323828104
- RosénCFarahmandBSkillbäckTBenchmarking biomarker-based criteria for Alzheimer’s disease: data from the Swedish Dementia Registry, SveDemAlzheimers Dement Epub201561